Immunohistochemical detection of lymph-node metastases (multiple letters)

Lancet

Volumn 355, Issue 9198, 2000, Pages 144-145

  Torrenga, H ^a   Rahusen, F D ^a   Borgstein, P J ^a   Meljer, S ^a   Van Diest, P J ^a   Bembenek, A ^a   Haensch, W ^a   Schneider, U ^a   Markwardt, J ^a   Schlag, P M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; AXILLA; BREAST TUMOR; FEMALE; NOTE; PATHOLOGY; BONE MARROW; PROGNOSIS;

TUMOR MARKER;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; TUMOR MARKERS, BIOLOGICAL; BONE MARROW; PROGNOSIS;

EID: 0034620168     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)72057-2     Document Type: Letter

References (5)

1. RJ Cote HF Peterson B Chaiwun Role of immunohistochemical detection of lymph-node metastases in metastases in management of breast cancer Lancet 354 1999 896 900 for the International Breast Cancer Study Group
2. U Veronesi G Paganelli V Galimberti Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes Lancet 349 1997 1864 1867
3. A Bembenek T Reuhl J Markwardt Sentinel lymph-node in breast cancer Swiss Surg 5 1999 217 221
4. B Fisher M Bauer L Wickerham Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update Cancer 52 1983 1551 1557
5. N Relihan G McGreal J Kelly Combined sentinel lymph-node mapping and bone marrow micrometastatic analysis for improved staging in breast cancer Lancet 354 1999 129 130